Here are five things to know:
1. ICER is among the few drug data sources the public can access.
2. BIO claims insurers are attempting to pass off their responsibility to pay for more effective, costlier drugs.
3. In one ICER report, the group found treatment prices ranging from $432 to $974 per treatment vial.
4. Many pharmaceuctical companies, including Bristol Myers Squibb and Amgen, have criticized the ICER reports.
5. ICER receives 10 percent of its funding from insurance companies and 17 percent of its funding from the drug lobby.
More articles on coding, billing & collections:
Medicare funds depleting fast; may run out of funds by 2028: 5 things to know
Providers may need to upgrade RCM systems to succeed in value-based world: 5 things to know
Obama administration deems new GOP health insurance proposal ‘not worthy’ — 4 takeaways
